Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 40 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

50%

20 trials in Phase 3/4

Results Transparency

0%

0 of 28 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

34Total
Not Applicable (8)
P 2 (6)
P 3 (12)
P 4 (8)

Trial Status

Completed28
Unknown7
Enrolling By Invitation2
Recruiting2
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 28 completed trials

Clinical Trials (40)

Showing 20 of 20 trials
NCT07416266Completed

Lower Respiratory Tract Infections Managed in Primary Care in France

NCT07111468Phase 3CompletedPrimary

Clinical Trial to Evaluate the Efficacy and Safety of YHP2401 Compared to YHR2402 and YHR2403 for Acute Bronchitis

NCT07383350Not ApplicableEnrolling By InvitationPrimary

Improving Patient-centered Communication and Antibiotic Use With Information Sheets for Acute Respiratory Tract Infections: A Study Protocol

NCT07359287Not ApplicableRecruiting

Impact of a Multimodal Intervention on Antibiotic Prescribing for Respiratory Infections in Primary Care

NCT05916768Not ApplicableCompletedPrimary

Management of Acute Bronchitis With Pelargonium Sidoides Extract

NCT07061925Phase 2CompletedPrimary

To Evaluate the Efficacy and Safety of ALC-2203 in Patients With Acute Bronchitis

NCT07198347Phase 3Not Yet RecruitingPrimary

Efficacy and Safety of AG2001 in Patients With Acute Bronchitis

NCT06411925Phase 4RecruitingPrimary

The Efficacy and Safety of Atock Dry Syrup With Acute Bronchitis Patients

NCT07093697Phase 3CompletedPrimary

A Study to Evaluate the Efficacy and Safety of DW5121 Compared to DW51211 and DW51212

NCT07030855Phase 4Enrolling By InvitationPrimary

Efficacy of Elixirium Thymi Compositum in the Treatment of Acute Bronchitis in Pediatric Patients

NCT05337163Completed

A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China

NCT06457269Not ApplicableCompleted

Evaluating the Potential of Large Language Models for Respiratory Disease Consultations

NCT06142994Not ApplicableCompletedPrimary

Treatment of Adults With Acute Bronchitis in the Primary Healthcare Setting

NCT06038084Phase 4CompletedPrimary

Evaluate the Efficacy and Safety of Acute Bronchitis Symptoms Improvement for Bronpass Tab. Compared to Erdos Capsule

NCT03711292Not ApplicableCompleted

Using Behavioral Science to Reduce Inappropriate Antibiotic Use in Acute Care Settings

NCT04239521Completed

The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata

NCT03738917Phase 4CompletedPrimary

Effectiveness of Antitussives, Anticholinergics and Honey Versus Usual Care in Adults With Acute Bronchitis.

NCT05344638Phase 3CompletedPrimary

A Clinical Trial to Evaluate the Safety and Efficacy of "AG1904" in Acute Bronchitis

NCT03011515Completed

Evaluating a Host-response Based Diagnostic for Distinguishing Between Bacterial and Viral Etiology in Patients With Lower Respiratory Tract Infection (LRTI)

NCT03657836Not ApplicableCompletedPrimary

The Sublimated Mare Milk Supplement's Effect on Gut Mucosal Lining After Antibiotics

Scroll to load more

Research Network

Activity Timeline